Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study

M. DI FORTI ; A. MARCONI ; E. CARRA ; S. FRAIETTA ; A. TROTTA ; M. BONOMO ; F. BIANCONI ; P. GARDNER-SOOD ; J. O'CONNOR ; M. RUSSO ; S. A. STILO ; T. R. MARQUES ; V. MONDELLI ; P. DAZZAN ; C. PARIANTE ; A. S. DAVID ; F. GAUGHRAN ; Z. ATAKAN ; C. IYEGBE ; J. POWELL ; C. MORGAN ; M. LYNSKEY ; R. M. MURRAY | 2015
Dans Lancet Psychiatry (The) (Vol.2, n°3, March 2015) Article : Périodique

Background: The risk of individuals having adverse effects from drug use (eg, alcohol) generally depends on the frequency of use and potency of the drug used. We aimed to investigate how frequent use of skunk-like (high-potency) cannabis in sout[...]

Plus d'info

Ajouter à la sélection

Lien externe

Seizure-induced by phosphodiesterase-5 inhibitors for recreational use: an emerging problem among young people! [Letter to the Editor]

R. S. CALABRO ; R. DE LUCA ; T. BALLETTA ; M. RUSSO ; A. NARO ; P. BRAMANTI | 2015
Dans Substance Use and Misuse (Vol.50, n°1, 2015) Article : Périodique

The introduction of sildenafil in 1998 can be considered the watershed in the pharmacological treatment of erectile dysfunction (ED), because of its broad efficacy for different types of ED. Since then, vardenafil, tadalafil and, more recently, [...]

Plus d'info

Ajouter à la sélection